PROTHENA CORPORATION PUBLIC LIMITED COMPANY Operating Leases, Future Minimum Payments Due, Next Twelve Months
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) had Operating Leases, Future Minimum Payments Due, Next Twelve Months of $23.00 thousand as of 2018-12-31, per its 10-K filed 2020-03-03.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent · last filed 2020-03-03
- 2018-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $23.00K.
- 2017-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $330.00K.
- 2017-09-30: Operating Leases, Future Minimum Payments Due, Next Twelve Months $103.00K.
- 2017-06-30: Operating Leases, Future Minimum Payments Due, Next Twelve Months $118.00K.
| Period end | Operating Leases, Future Minimum Payments Due, Next Twelve Months |
|---|---|
| 2018-12-31 | $23.00K 10-K · filed 2020-03-03 |
| 2017-12-31 | $330.00K 10-K · filed 2018-02-26 |
| 2017-09-30 | $103.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $118.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $166.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $2.23M 10-K · filed 2017-02-27 |
| 2016-09-30 | $552.00K 10-Q · filed 2016-11-02 |
| 2016-06-30 | $1.09M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $1.63M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $2.13M 10-K · filed 2016-02-25 |
| 2014-12-31 | $1.82M 10-K · filed 2015-03-13 |
| 2014-09-30 | $368.00K 10-Q · filed 2014-11-04 |
| 2014-06-30 | $661.00K 10-Q · filed 2014-08-05 |
| 2014-03-31 | $980.00K 10-Q · filed 2014-05-05 |
| 2013-12-31 | $1.30M 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |